Corcept Therapeutics
CORT
#2334
Rank
NZ$13.65 B
Marketcap
NZ$127.20
Share price
1.90%
Change (1 day)
8.58%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: NZ$13.65 Billion

As of June 2026 Corcept Therapeutics has a market cap of NZ$13.65 Billion. This makes Corcept Therapeutics the world's 2334th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$13.65 B-9.2%
2025NZ$15.03 B54.26%
2024NZ$9.74 B84.12%
2023NZ$5.29 B53.74%
2022NZ$3.44 B2.9%
2021NZ$3.34 B-20.54%
2020NZ$4.21 B104.66%
2019NZ$2.05 B-10.17%
2018NZ$2.29 B-21.05%
2017NZ$2.90 B149.38%
2016NZ$1.16 B45.87%
2015NZ$0.79 B105.49%
2014NZ$0.38 B-0.46%
2013NZ$0.39 B124.79%
2012NZ$0.17 B-52.99%
2011NZ$0.36 B1.89%
2010NZ$0.36 B51.5%
2009NZ$0.23 B173.39%
2008NZ$87.46 M-45.17%
2007NZ$0.15 B255.11%
2006NZ$44.92 M-62.84%
2005NZ$0.12 B-39.03%
2004NZ$0.19 B

End of Day market cap according to different sources

On Jun 7th, 2026 the market cap of Corcept Therapeutics was reported to be:

NZ$13.39 Billion
by Nasdaq info icon info icon
NZ$13.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$957.09 B 6,909.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$480.67 B 3,420.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$251.07 B 1,738.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.772 T 12,877.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$503.89 B 3,590.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$196.27 B 1,337.42%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$1.81 B-86.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$1.39 B-89.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$18.70 B 36.98%๐Ÿ‡บ๐Ÿ‡ธ USA